Provention Bio, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Oldwick NJ United States (2016)

Organization Overview

First Clinical Trial
2018
NCT03849599
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Provention Bio | Provention Bio, Inc.